epigallocatechin gallate has been researched along with Carcinoma, Epidermoid in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (8.51) | 18.2507 |
2000's | 16 (34.04) | 29.6817 |
2010's | 25 (53.19) | 24.3611 |
2020's | 2 (4.26) | 2.80 |
Authors | Studies |
---|---|
Baran, I; Ganea, C; Georgescu, L; Katona, E; Mocanu, MM; Nagy, P; Shrestha, D; Szöllősi, J; Váradi, T | 1 |
Brebi, P; Buchegger, K; Ili, C; Kurachi, C; León, D; Mora-Lagos, B; Riquelme, I; Roa, JC; Schafer, F; Silva, R; Viscarra, T; Zanella, L | 1 |
Chen, L; Guo, X; Hu, Y; Li, L; Liang, G; Zhang, G | 1 |
López Jornet, P; Pons-Fuster López, E; Wang, QT; Wei, W | 1 |
Ju, Y; Liu, L; Wang, J; Zhou, R | 1 |
Chen, X; Fu, X; Gu, K; Li, A; Wang, Q; Wang, Y; Wen, Y | 1 |
Kiyoshima, T; Kobayashi, M; Matsuda, S; Ohmori, M; Ohta, K; Ryoke, T; Sano, K; Yamamoto, S; Yoshida, H; Yoshimura, H | 1 |
Chung, WY; Hwang, YS; Park, KK | 1 |
Kang, HJ; Kwon, HW; Lee, SH; Lim, YC; Nam, HJ | 1 |
Akanuma, N; Akutsu, Y; Hanari, N; Hoshino, I; Isozaki, Y; Maruyama, T; Matsubara, H; Mori, M; Murakami, K; Nakayama, T; Nishimori, T; Suito, H; Suzuki, A; Takahashi, M; Takeshita, N; Toyozumi, T | 1 |
Gu, S; Hou, L; Huang, S; Liu, L; Luo, M; Meng, D; Zhang, X; Zhao, X; Zuo, X | 1 |
Gao, F; Li, JL; Li, M; Liu, WB; Zhang, R; Zhou, KC; Zhou, ZS | 1 |
Chen, WT; Chen, YJ; Chung, LC; Feng, TH; Juang, HH; Lee, JC | 1 |
Chen, LL; Geng, Y; Han, WF; Su, JS | 1 |
Katiyar, SK | 1 |
Chen, Z'; Khuri, FR; Lee, JE; Shin, DM; Shin, HJ; Tighiouart, M; Yang, CS; Zhang, H; Zhang, X | 1 |
Hara, A; Hatakeyama, D; Kato, K; Long, NK; Makita, H; Mori, H; Shibata, T; Toida, M; Yamashita, T | 1 |
Amin, AR; Chen, ZG; Khuri, FR; Shin, DM | 1 |
Jeong, YJ; Jung, JY; Kim, D; Kim, SH; Kim, WJ; Lee, JH; Lee, SW; Lim, HS; Oh, HK; Oh, SJ | 1 |
Adhikary, G; Balasubramanian, S; Eckert, RL | 1 |
Amin, AR; Kim, JW; Shin, DM | 1 |
Amin, AR; Rahman, MA; Shin, DM | 1 |
Chen, PN; Chou, MY; Chu, SC; Hsieh, YS; Kuo, WH; Lin, JK | 1 |
Liu, X; Ye, F; Yuan, C; Zhang, DY; Zhang, W; Zhao, X | 1 |
Chen, SC; Funayama, S; Ho, CT; Hou, SC; Kao, MC; Lin, HY; Way, TD; Yu, CC | 1 |
Chang, YC; Ho, YC; Lee, SS; Tsai, CH; Yu, CC | 1 |
Amor, R; Blatchford, DR; Chang, CW; Dufès, C; Lemarié, F; McConnell, G; Norris, G; Tetley, L | 1 |
Amagaya, S; Chang, CM; Chang, PY; Chen, MY; Jao, HY; Kuo, SC; Lee, CY; Lu, CC; Tu, MG; Yang, JS | 1 |
Baek, SJ; Kang, SU; Kim, CH; Lee, BS; Lee, SH; Shin, YS | 1 |
Cai, GM; Hunag, DH; Liu, Y; Pi, LM; Qiu, YZ; Tian, YQ; Yu, CY; Zhang, X | 1 |
Chang, KW; Chen, YM; Fann, MJ; Kao, SY; Lin, SC; Liu, CJ; Lu, SY; Wang, CP | 1 |
Liu, J; Mei, Y; Wei, D | 1 |
Cho, KH; Chung, JH; Eun, HC; Han, JH; Hwang, EJ; Kim, KH; Seo, JY; Youn, JI | 1 |
Ai, N; Fang, MZ; Hou, Z; Lu, H; Sun, Y; Wang, Y; Welsh, W; Yang, CS | 1 |
Afaq, F; Ahmad, N; Gupta, S; Hastak, K; Mukhtar, H | 1 |
Cao, Y; Luo, FJ; Tang, M; Wang, H; Zhao, XR; Zhao, Y | 1 |
Babich, H; Sedaghat, T; Weisburg, JH; Weissman, DB | 1 |
Babich, H; Krupka, ME; Nissim, HA; Zuckerbraun, HL | 1 |
Chin, KV; Hong, J; Hou, Z; Lee, MJ; Sang, S; Yang, CS; You, H | 1 |
Chang, KW; Chiang, WC; Lin, SC; Liu, CJ; Wong, YK | 1 |
Chang, KW; Hsu, HC; Ko, SY; Lin, SC; Liu, TY | 1 |
Agarwal, R; Katiyar, SK; Mohan, RR; Mukhtar, H | 1 |
Chen, CF; Liang, YC; Lin, JK; Lin-shiau, SY | 1 |
al-Rawi, M; Edelstein, D; Khafif, A; Sacks, PG; Schantz, SP | 1 |
Chen, YC; Ho, CT; Liang, YC; Lin, JK; Lin, YL; Lin-Shiau, SY | 1 |
Fujiki, H; Fujimoto, N; Goto, Y; Imai, K; Matsuyama, S; Nakachi, K; Okabe, S; Sueoka, E; Sueoka, N; Suganuma, M | 1 |
Agarwal, C; Agarwal, R; Bhatia, N | 1 |
4 review(s) available for epigallocatechin gallate and Carcinoma, Epidermoid
Article | Year |
---|---|
Emerging Phytochemicals for the Prevention and Treatment of Head and Neck Cancer.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Evaluation, Preclinical; Head and Neck Neoplasms; Humans; Lignans; Magnolia; Polyphenols; Proanthocyanidins; Squamous Cell Carcinoma of Head and Neck; Tea; Vitis | 2016 |
Chemoprevention of head and neck cancer with green tea polyphenols.
Topics: Animals; Carcinoma, Squamous Cell; Catechin; Chemoprevention; Flavonoids; Head and Neck Neoplasms; Humans; Models, Biological; Phenols; Plant Extracts; Polyphenols; Tea | 2010 |
Chemopreventive potential of natural compounds in head and neck cancer.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Catechin; Curcumin; Cyclooxygenase 2 Inhibitors; ErbB Receptors; Head and Neck Neoplasms; Humans; NF-kappa B; Resveratrol; Stilbenes; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2010 |
Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1.
Topics: Animals; Anticarcinogenic Agents; Biomarkers, Tumor; Carcinoma, Squamous Cell; Catechin; Chemoprevention; Cohort Studies; Drug Synergism; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Heterogeneous-Nuclear Ribonucleoproteins; Humans; Intestinal Neoplasms; Japan; Lung Neoplasms; Male; Mice; Mice, Mutant Strains; Okadaic Acid; Oligonucleotide Array Sequence Analysis; Prospective Studies; Ribonucleoproteins; Sulindac; Tea; Tumor Cells, Cultured | 2001 |
43 other study(ies) available for epigallocatechin gallate and Carcinoma, Epidermoid
Article | Year |
---|---|
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
Topics: Algorithms; Anticarcinogenic Agents; Apoptosis; Carcinoma, Squamous Cell; Catechin; Cell Proliferation; Down-Regulation; ErbB Receptors; Female; Flavonoids; G2 Phase Cell Cycle Checkpoints; Genes, erbB-1; Genes, erbB-2; Genistein; Glycine max; Humans; Molecular Structure; Polyphenols; Receptors, Laminin; Ribosomal Proteins; Tea | 2014 |
Epigallocatechin Gallate Enhances MAL-PDT Cytotoxic Effect on PDT-Resistant Skin Cancer Squamous Cells.
Topics: Aminolevulinic Acid; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Catechin; Cell Death; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modality Therapy; Ferrochelatase; Heat-Shock Proteins; Humans; Membrane Transport Proteins; Molecular Chaperones; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Reactive Oxygen Species; Skin Neoplasms; Stress, Physiological; Superoxide Dismutase; Survivin; Symporters | 2020 |
Epigallocatechin-3-gallate sensitises multidrug-resistant oral carcinoma xenografts to vincristine sulfate.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Catechin; Cell Proliferation; Chick Embryo; Chickens; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Injections, Intraperitoneal; KB Cells; Mice; Mice, Nude; Mouth Neoplasms; Neoplasms, Experimental; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vincristine | 2020 |
Potential chemotherapeutic effects of diosgenin, zoledronic acid and epigallocatechin-3-gallate on PE/CA-PJ15 oral squamous cancer cell line.
Topics: Apoptosis; Carcinoma, Squamous Cell; Catechin; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Survival; Diosgenin; Diphosphonates; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Imidazoles; Mouth Neoplasms; Zoledronic Acid | 2017 |
Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; ATP Binding Cassette Transporter, Subfamily G, Member 2; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Membrane Potential, Mitochondrial; Neoplasm Proteins; Signal Transduction; Time Factors | 2017 |
Epigallocatechin-3-gallate affects the proliferation, apoptosis, migration and invasion of tongue squamous cell carcinoma through the hippo-TAZ signaling pathway.
Topics: Apoptosis; Carcinoma, Squamous Cell; Catechin; Cell Line; Cell Movement; Cell Proliferation; Humans; Signal Transduction; Tongue Neoplasms; Wound Healing | 2018 |
The therapeutic potential of epigallocatechin‑3‑gallate against human oral squamous cell carcinoma through inhibition of cell proliferation and induction of apoptosis: In vitro and in vivo murine xenograft study.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Proliferation; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Xenograft Model Antitumor Assays | 2019 |
Epigallocatechin-3 gallate inhibits cancer invasion by repressing functional invadopodia formation in oral squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Catechin; Cell Membrane; Cell Movement; Cell Proliferation; Cortactin; Extracellular Matrix; Focal Adhesion Kinase 1; Gene Expression Regulation, Neoplastic; Humans; Male; Matrix Metalloproteinases; Mice; Mice, Inbred BALB C; Mouth Neoplasms; Neoplasm Invasiveness; Phosphorylation; Proto-Oncogene Proteins pp60(c-src); rhoA GTP-Binding Protein; Xenograft Model Antitumor Assays | 2013 |
Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Proliferation; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Multidrug Resistance-Associated Protein 2; Neoplastic Stem Cells; Receptors, Notch; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Transfection; Xenograft Model Antitumor Assays | 2013 |
Screening of alternative drugs to the tumor suppressor miR-375 in esophageal squamous cell carcinoma using the connectivity map.
Topics: Antineoplastic Agents; Apoptosis; Benzocaine; Betazole; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Chenodeoxycholic Acid; Cytotoxins; DNA Primers; Esophageal Neoplasms; Humans; In Situ Nick-End Labeling; Metformin; MicroRNAs; Nizatidine; Organophosphates; Proline; Protein Array Analysis; Real-Time Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones; Transcriptome; Transfection; Tumor Suppressor Proteins | 2014 |
Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Catechin; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; G1 Phase Cell Cycle Checkpoints; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Reactive Oxygen Species; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2015 |
Epigallocatechin gallate inhibits human tongue carcinoma cells via HK2‑mediated glycolysis.
Topics: Anticarcinogenic Agents; Apoptosis; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Proliferation; Chemoprevention; Enzyme Activation; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Glycolysis; Hexokinase; Humans; Mitochondrial Membranes; Proto-Oncogene Proteins c-akt; Tongue Neoplasms | 2015 |
Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells.
Topics: Animals; Carcinoma, Squamous Cell; Catechin; Cell Growth Processes; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; G1 Phase Cell Cycle Checkpoints; Gene Knockdown Techniques; Head and Neck Neoplasms; Humans; Immediate-Early Proteins; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; p38 Mitogen-Activated Protein Kinases; Squamous Cell Carcinoma of Head and Neck; Tumor Suppressor Proteins; Up-Regulation; Xenograft Model Antitumor Assays | 2015 |
A genome-wide study of DNA methylation modified by epigallocatechin-3-gallate in the CAL-27 cell line.
Topics: Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Proliferation; Computational Biology; DNA Methylation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Humans; Mouth Neoplasms; Signal Transduction | 2015 |
Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Proliferation; Disease Progression; Drug Synergism; Enzyme Inhibitors; ErbB Receptors; Erlotinib Hydrochloride; Flow Cytometry; Fluorescent Antibody Technique; Head and Neck Neoplasms; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mice, Nude; Protein-Tyrosine Kinases; Quinazolines; Transplantation, Heterologous | 2008 |
Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells.
Topics: Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Movement; DNA Methylation; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Membrane Glycoproteins; Mouth Neoplasms; Neoplasm Invasiveness; Polymerase Chain Reaction; Promoter Regions, Genetic; RNA, Messenger; RNA, Neoplasm; Tea | 2008 |
Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Squamous Cell; Catechin; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; NF-kappa B; Protein Kinase Inhibitors; Quinazolines; RNA, Small Interfering; Transcription Factor RelA; Tumor Suppressor Protein p53 | 2009 |
EGCG induces apoptosis in human laryngeal epidermoid carcinoma Hep2 cells via mitochondria with the release of apoptosis-inducing factor and endonuclease G.
Topics: Anticarcinogenic Agents; Apoptosis Inducing Factor; Blotting, Western; Carcinoma, Squamous Cell; Catechin; Cell Cycle; Cell Line, Tumor; Endodeoxyribonucleases; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Laryngeal Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Tumor Suppressor Protein p53 | 2010 |
The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.
Topics: Anticarcinogenic Agents; Apoptosis; Carcinoma, Squamous Cell; Catechin; Cell Count; Cell Cycle Proteins; Cell Line, Transformed; Cell Line, Tumor; Culture Media, Serum-Free; DNA Replication; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Knockdown Techniques; Genetic Vectors; Humans; Keratinocytes; Neoplasm Proteins; Nuclear Proteins; Polycomb Repressive Complex 1; Polycomb Repressive Complex 2; Polycomb-Group Proteins; Proto-Oncogene Proteins; Recombinant Fusion Proteins; Repressor Proteins; Skin Neoplasms; Transcription Factors | 2010 |
Epigallocatechin-3 gallate inhibits invasion, epithelial-mesenchymal transition, and tumor growth in oral cancer cells.
Topics: Base Sequence; Carcinoma, Squamous Cell; Catechin; Cell Division; Cell Line, Tumor; DNA Primers; Epithelial-Mesenchymal Transition; Fluorescent Antibody Technique; Humans; Mouth Neoplasms; Neoplasm Invasiveness; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma.
Topics: Anticarcinogenic Agents; Antioxidants; Carcinoma, Squamous Cell; Catechin; Cell Cycle; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Phosphorylation; Plant Extracts; Signal Transduction; Tea | 2011 |
(-)-Epigallocatechin gallate induces Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells.
Topics: Apoptosis; Carcinoma, Squamous Cell; Catechin; Down-Regulation; Fas Ligand Protein; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Interleukin-6; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; STAT3 Transcription Factor | 2012 |
Heat shock protein 27 expression in areca quid chewing-associated oral squamous cell carcinomas.
Topics: Acetylcysteine; Areca; Arecoline; Carcinoma, Squamous Cell; Case-Control Studies; Catechin; Cyclooxygenase 2 Inhibitors; Down-Regulation; Female; Flavonoids; Gene Expression; Gene Expression Regulation, Neoplastic; HSP27 Heat-Shock Proteins; Humans; Imidazoles; Male; Middle Aged; Mouth Neoplasms; Nitrobenzenes; Pyridines; Quercetin; Sulfonamides | 2012 |
Antitumor activity of the tea polyphenol epigallocatechin-3-gallate encapsulated in targeted vesicles after intravenous administration.
Topics: Administration, Intravenous; Animals; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Female; Humans; Melanoma; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Tea; Xenograft Model Antitumor Assays | 2013 |
Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Drug Synergism; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Gefitinib; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mouth Neoplasms; Neoplasm Metastasis; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Wound Healing | 2012 |
Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression.
Topics: Anticarcinogenic Agents; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Growth Differentiation Factor 15; Head and Neck Neoplasms; Heterografts; Humans; RNA, Small Interfering; Squamous Cell Carcinoma of Head and Neck; Tumor Suppressor Protein p53 | 2013 |
[EGCG regulates TGF-β1-induced epithelial mesenchymal transition in squamous cell carcinoma of head and neck].
Topics: Antigens, CD; Cadherins; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Head and Neck Neoplasms; Humans; Signal Transduction; Smad7 Protein; Squamous Cell Carcinoma of Head and Neck; Transforming Growth Factor beta1; Vimentin | 2012 |
Regulation of IGFBP-5 expression during tumourigenesis and differentiation of oral keratinocytes.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Catechin; Cell Differentiation; Cell Transformation, Neoplastic; Down-Regulation; Gene Expression Regulation, Neoplastic; Gene Library; Humans; Insulin-Like Growth Factor Binding Protein 5; Keratinocytes; Male; Middle Aged; Mouth Neoplasms; Neoplasm Proteins; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Up-Regulation | 2002 |
Quantification of doxorubicin and validation of reversal effect of tea polyphenols on multidrug resistance in human carcinoma cells.
Topics: Carcinoma, Squamous Cell; Catechin; Cell Division; Cell Survival; Chromatography, High Pressure Liquid; Doxorubicin; Drug Resistance, Multiple; Flavonoids; Humans; Mouth Neoplasms; Phenols; Polymers; Tea; Tumor Cells, Cultured | 2003 |
Dual mechanisms of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes.
Topics: Apoptosis; bcl-2-Associated X Protein; bcl-Associated Death Protein; Carcinoma, Squamous Cell; Carrier Proteins; Catechin; Cell Division; Cell Survival; Cells, Cultured; Epidermal Cells; Humans; Keratinocytes; Mitogen-Activated Protein Kinases; Models, Biological; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Skin Neoplasms; Tumor Cells, Cultured | 2003 |
Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.
Topics: Adaptor Proteins, Signal Transducing; Anticarcinogenic Agents; Antineoplastic Agents; Carcinoma, Squamous Cell; Carrier Proteins; Catechin; Cell Division; Cell Line, Tumor; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, p16; Humans; Models, Molecular; MutL Protein Homolog 1; Neoplasm Proteins; Nuclear Proteins; O(6)-Methylguanine-DNA Methyltransferase; Receptors, Retinoic Acid | 2003 |
Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Carcinoma, Squamous Cell; Caspase Inhibitors; Caspases; Catechin; Cell Line, Tumor; Cell Nucleus; Cell Survival; DNA; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Male; Models, Biological; NF-kappa B; Oligopeptides; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Protein Structure, Tertiary; Time Factors; Transcription, Genetic | 2004 |
[Epigallocatechin-3-gallate interferes with EBV-encoding AP-1 signal transduction pathway].
Topics: Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Survival; Herpesvirus 4, Human; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Nasopharyngeal Neoplasms; Phosphorylation; Protein Transport; Proto-Oncogene Proteins c-jun; Signal Transduction; Transcription Factor AP-1; Viral Matrix Proteins | 2004 |
In vitro cytotoxicity of epigallocatechin gallate and tea extracts to cancerous and normal cells from the human oral cavity.
Topics: Anticarcinogenic Agents; Camellia sinensis; Carcinoma, Squamous Cell; Catechin; Humans; Lipid Peroxidation; Mouth; Oxidative Stress; Plant Extracts; Tea; Tongue Neoplasms; Tumor Cells, Cultured | 2004 |
Differential in vitro cytotoxicity of (-)-epicatechin gallate (ECG) to cancer and normal cells from the human oral cavity.
Topics: Antioxidants; Apoptosis; Carcinoma, Squamous Cell; Catechin; Cell Survival; DNA; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fibroblasts; Gingiva; Humans; Mouth Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2005 |
Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
Topics: Benzopyrans; Biflavonoids; Carcinoma, Squamous Cell; Catechin; Cell Growth Processes; Cell Line, Tumor; Drug Stability; ErbB Receptors; Esophageal Neoplasms; Gallic Acid; Humans; Oxidation-Reduction; Phenols; Phosphorylation; Receptor, ErbB-2; Superoxide Dismutase | 2005 |
Increase of MMP-13 expression in multi-stage oral carcinogenesis and epigallocatechin-3-gallate suppress MMP-13 expression.
Topics: Adult; Aged; Anticarcinogenic Agents; Blotting, Western; Carcinoma, Squamous Cell; Catechin; Collagenases; Electrophoresis, Polyacrylamide Gel; Humans; Immunohistochemistry; Matrix Metalloproteinase 13; Matrix Metalloproteinase Inhibitors; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Protease Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2006 |
The repressive effect of green tea ingredients on amyloid precursor protein (APP) expression in oral carcinoma cells in vitro and in vivo.
Topics: Amyloid beta-Protein Precursor; Animals; Blotting, Western; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Phytotherapy; Plant Preparations; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tea | 2007 |
Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenols.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antioxidants; Carcinoma, Squamous Cell; Catechin; Cocarcinogenesis; Disease Progression; Diterpenes; Flavonoids; Mice; Mice, Inbred SENCAR; Papilloma; Phenols; Plant Extracts; Polymers; Skin Neoplasms; Tea; Terpenes | 1997 |
Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Catechin; Cell Division; DNA, Neoplasm; Epidermal Growth Factor; ErbB Receptors; Humans; Ligands; Phosphotyrosine; Receptor Protein-Tyrosine Kinases; Receptors, Fibroblast Growth Factor; Receptors, Platelet-Derived Growth Factor; Signal Transduction; Tea; Tumor Cells, Cultured | 1997 |
Green tea regulates cell cycle progression in oral leukoplakia.
Topics: Anticarcinogenic Agents; Blotting, Western; Carcinoma, Squamous Cell; Catechin; Cell Division; Cell Transformation, Neoplastic; Cells, Cultured; Child, Preschool; Humans; Leukoplakia, Oral; Models, Biological; Mouth Mucosa; Phytotherapy; Sensitivity and Specificity; Skin Neoplasms; Tea | 1998 |
Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3'-digallate.
Topics: 3T3 Cells; Animals; Biflavonoids; Carcinoma, Squamous Cell; Catechin; Cell Division; Epidermal Growth Factor; ErbB Receptors; Gallic Acid; Growth Inhibitors; Humans; Laryngeal Neoplasms; Mice; Phenols; Phosphorylation; Platelet-Derived Growth Factor; Polyphenols; Protein Binding; Protein Processing, Post-Translational; Receptors, Platelet-Derived Growth Factor; Signal Transduction; Tea; Tumor Cells, Cultured | 1999 |
Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Anticarcinogenic Agents; Apoptosis; Carcinoma, Squamous Cell; Catechin; CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Enzyme Inhibitors; ErbB Receptors; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Mitogens; Phosphorylation; Protein Serine-Threonine Kinases; Proteins; Proto-Oncogene Proteins; Quercetin; Shc Signaling Adaptor Proteins; Signal Transduction; Silymarin; Skin Neoplasms; Src Homology 2 Domain-Containing, Transforming Protein 1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2001 |